Y-mAbs Therapeutics, Inc. (YMAB) Income Quarterly - Discounting Cash Flows
YMAB
Y-mAbs Therapeutics, Inc.
YMAB (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
Report Filing 2025-08-08 2025-08-08 2025-05-13 2025-03-04 2024-11-08 2024-08-12 2024-05-07
1234
Revenue 85.39 19.52 20.9 26.5 18.46 22.8 19.93
1234
Cost of Revenue 15.75 2.66 3 7.84 2.25 3.01 2.15
1234
Gross Profit 69.63 16.86 17.9 18.65 16.21 19.78 17.78
1234
Operating Expenses 96.28 22.47 24.45 24.59 24.78 29.57 24.69
1234
Research & Development 45.84 11.1 11.36 12.21 11.17 12.34 13.27
1234
Selling, General and Administrative 50.39 11.31 13.09 12.38 13.61 17.23 11.43
1234
Other Operating Expenses 0.05 0.05 0 0 0 0 0
1234
Operating Income -26.65 -5.6 -6.54 -5.94 -8.57 -9.79 -6.91
1234
Net Non-Operating Interest 1.66 0 1.35 -1.61 1.92 0.64 0.439
1234
Interest Income 1.66 0 1.35 -1.61 1.92 0.64 0.439
1234
Interest Expense 0 0 0 0 0 0 0
1234
Equity & Other Income/(Expense) 2.37 2.37 0 0 0 0 0
1234
Income Before Tax -22.62 -3.23 -5.19 -7.54 -6.65 -9.15 -6.47
1234
Income Tax Expense -0.394 0.007 0.005 -0.752 0.346 0.1 0.16
1234
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0
1234
Net Income -22.22 -3.24 -5.2 -6.79 -7 -9.25 -6.63
1234
Depreciation and Amortization 0.294 0 0.071 0.102 0.121 0.153 0.159
1234
EBITDA -26.36 -5.6 -6.47 -5.83 -8.45 -9.64 -6.75
1234
Earnings Per Share (EPS) -0.502 -0.071 -0.12 -0.15 -0.16 -0.21 -0.15
1234
Diluted Earnings Per Share -0.502 -0.071 -0.12 -0.15 -0.16 -0.21 -0.15
1234
Weighted Average Shares Outstanding 45.32 45.32 45.1 44.88 44.63 44.02 43.78
1234
Diluted Weighted Average Shares Outstanding 45.32 45.32 45.1 44.88 44.63 44.02 43.78
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program